Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Spyre Therapeutics
AddedFeb 19, 2024
UpdatedJul 9, 2026
Spyre Therapeutics

Spyre Therapeutics

Public

US-based Spyre Therapeutics develops precise immunology and therapeutic combinations for IBD and chronic inflammation.

HQ
Austin, TX, US
Founded
2013
Overview
Compare
Fundraising
Employees
Website

Spyre Therapeutics, Inc. is a biotechnology company based in the United States, founded with the mission to improve treatment options for Inflammatory Bowel Disease (IBD) and chronic inflammation diseases. The company focuses on developing best-in-class antibodies, rational therapeutic combinations, and precision immunology approaches aimed at providing therapies with high efficacy and convenience for conditions such as ulcerative colitis (UC). Spyre Therapeutics is dedicated to addressing unmet medical needs within the IBD market.

The company boasts a team with extensive experience in developing and commercializing treatments. Notable affiliated individuals and investors have not been specified, but the company's achievements include advancing a robust pipeline of potential therapies. Spyre Therapeutics' impact lies in its innovative approach to treating IBD, aiming to significantly enhance the quality of life for patients through cutting-edge biotechnological solutions.

Spyre Therapeutics - Similar Companies

Precision IBD logo

Precision IBD

Spyryx Biosciences logo

Spyryx Biosciences

Osprey Pharmaceuticals USA logo

Osprey Pharmaceuticals USA

ospreypharma.com

SphynKx Therapeutics logo

SphynKx Therapeutics

Synspira logo

Synspira

Aegle Therapeutics logo

Aegle Therapeutics

Elgia Therapeutics logo

Elgia Therapeutics

Sorriso Pharmaceuticals logo

Sorriso Pharmaceuticals

sorrisopharma.com

Halia Therapeutics logo

Halia Therapeutics

Aristea Therapeutics logo

Aristea Therapeutics

Spero Therapeutics logo

Spero Therapeutics

Therini Bio logo

Therini Bio

therinibio.com

Star Therapeutics logo

Star Therapeutics

Sparrow Pharmaceuticals logo

Sparrow Pharmaceuticals

sparrowpharma.com

Spiral Therapeutics logo

Spiral Therapeutics

spiraltx.com

Spyre Therapeutics - Quick Facts

Who are Spyre Therapeutics' competitors?

Companies similar to Spyre Therapeutics include Precision IBD, Spyryx Biosciences, Osprey Pharmaceuticals USA and SphynKx Therapeutics.

When was Spyre Therapeutics founded?

Spyre Therapeutics was founded in 2013.

Where is Spyre Therapeutics' headquarters located?

Spyre Therapeutics' headquarters is located in Austin, TX, US.

When was Spyre Therapeutics' last funding round?

Spyre Therapeutics' most recent funding round was for $210M (USD) in June 2023.

How much has Spyre Therapeutics raised to-date?

As of Jun 22, 2023, Spyre Therapeutics has raised a total of $266M (USD).

How many employees does Spyre Therapeutics have?

Spyre Therapeutics has 69 employees as of Feb 6, 2024.

Spyre Therapeutics - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Antibodies
  • Therapeutics
Unique IDs
  • secCik: 0001636282
  • ticker: SYRE
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 14 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 4000Railroad Transportation
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified